Synergistic growth inhibition by acyclic retinoid and vitamin K2 in human hepatocellular carcinoma cells. [electronic resource]
- Cancer science Mar 2007
- 431-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1347-9032
10.1111/j.1349-7006.2006.00384.x doi
Antineoplastic Agents--pharmacology Carcinoma, Hepatocellular--drug therapy Cell Line, Tumor Dose-Response Relationship, Drug Drug Synergism Humans Liver Neoplasms--drug therapy Tretinoin--analogs & derivatives Vitamin K 2--therapeutic use